BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11893750)

  • 1. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.
    Strano S; Fontemaggi G; Costanzo A; Rizzo MG; Monti O; Baccarini A; Del Sal G; Levrero M; Sacchi A; Oren M; Blandino G
    J Biol Chem; 2002 May; 277(21):18817-26. PubMed ID: 11893750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53.
    Klein C; Georges G; Künkele KP; Huber R; Engh RA; Hansen S
    J Biol Chem; 2001 Oct; 276(40):37390-401. PubMed ID: 11477076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CP-31398 restores DNA-binding activity to mutant p53 in vitro but does not affect p53 homologs p63 and p73.
    Demma MJ; Wong S; Maxwell E; Dasmahapatra B
    J Biol Chem; 2004 Oct; 279(44):45887-96. PubMed ID: 15308639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a distinct inhibitory factor in the regulation of p53 functional activity.
    Wiederschain D; Gu J; Yuan ZM
    J Biol Chem; 2001 Jul; 276(30):27999-8005. PubMed ID: 11382762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
    Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
    Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interaction between p53 mutants and different isoforms of p73.
    Strano S; Munarriz E; Rossi M; Cristofanelli B; Shaul Y; Castagnoli L; Levine AJ; Sacchi A; Cesareni G; Oren M; Blandino G
    J Biol Chem; 2000 Sep; 275(38):29503-12. PubMed ID: 10884390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
    Mondal N; Parvin JD
    Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
    Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
    Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
    Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
    FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.